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Abstract 
 
Nanotechnology is a rapidly growing field with silver (AgNP) nanoparticles in particular 
utilized in a wide variety of consumer products. This has presented a number of concerns 
relating to exposure and the associated toxicity to humans and the environment. As inhalation 
is the most common exposure route, this study investigates the potential toxicity of AgNP to 
A549 alveolar epithelial carcinoma cells and the influence of a major component of lung 
surfactant dipalmitoylphosphatidylcholine (DPPC) on toxicity. It was illustrated that exposure 
to AgNP generated low levels of oxidative stress and a reduction in cell viability. While the 
presence of DPPC caused no influence on viability studies its presence increased reactive 
oxygen species (ROS) formation. DPPC also significantly modified the inflammatory response 
generated by AgNP exposure. These findings suggest a possible interaction between AgNP and 
DPPC causing particles to become more reactive thus increasing oxidative insult and 
inflammatory response within A549 cells. 
 
Short Abstract 
Inhalation presents as the most common route of silver (AgNP) nanoparticle exposure. As such 
its interaction with pulmonary surfactant may influence the biological response induced. 
Toxicological testing was performed on the A549 cell line and demonstrated toxicity induced 
by AgNP exposure. Significant changes in acute responses including ROS generation and 
inflammatory marker release was noted. It is postulated the presence of DPPC interacts with 
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AgNP producing a more reactive particle resulting in modification of acute responses at low 
dose exposures. 
 
Introduction 
 
Nanoparticle exposure via inhalation is probably the most common entry point for 
nanoparticles and during recent decades the generation of engineered nanoparticles for 
applications in medicine, food, cosmetics and electronics to name a few has increased the 
likelihood of exposure exponentially (Sozar & Kokini, 2009; Bouwmeester et al, 2009).  
Inhalation provides an easy entry route for engineered nanoparticles in nano-carrier systems 
for drug delivery allowing an easy route for targeted, controlled and non-invasive delivery. 
Liposomes in particular have been the nano-carrier of choice in the development of improved 
and intelligent drug delivery systems (Varez-Lorenzo et al, 2009; Shum et al, 2001). While 
inhalation provides an alternative method of pharmaceutical delivery, improving both the 
treatment and comfort of patients, it can be a double edged sword and increase the delivery of 
undesirable effects of nanoparticles. A number of studies have been undertaken to explore lung 
entry of various nanoparticles and their subsequent distribution around the body. Cerium oxide 
(CeO2) nanoparticles have been shown to cause acute toxicity in the lungs following exposure. 
It was postulated that this could possibly lead to chronic inflammation days after the exposure 
period with particles deposited in the lungs as they penetrate through the alveolar wall into the 
systemic circulation (Srinivas et al, 2010). Silver (AgNP) nanoparticle exposure in the lung 
has also been shown to induce cytotoxicity along with zinc oxide (ZnO) and titanium dioxide 
(TiO2). Although all nanometals induced toxicity they did so at differing levels with ZnO 
inducing greater levels of toxicity in alveolar macrophages compared with the other two 
nanometals. The induced toxicity may also lead to excessive secretion of certain biological 
agents causing dysfunction in the cytokine network, reducing the efficiency of the respiratory 
immune system (Liu et al, 2013). 
Due mainly to their antibacterial qualities AgNP are currently one of the most utilized 
nanomaterials on the market providing a diverse range of applications including medical 
devices, antibacterial textiles and toys and food packaging (Sozar & Kokini, 2009; 
Bouwmeester et al, 2009). While AgNP have been highly regarded for their benefits, their 
increased incorporation into everyday consumer products has generated considerable interest 
in establishing the risk exposure has on human health and the environment. A more in depth 
toxicological assessment of nanoparticle-biological interaction is required and a focus must 
now be shifted onto the influence of biofluids (any fluid within the body that can be secreted, 
excreted, obtained with a needle or develop due to a pathological process (Medicinenet)) and 
surfactants on toxicological outcome (Mwilu et al, 2013; Ehrenberg et al, 2009; Wang et al, 
2013; Misra et al, 2012; Aggarwal et al, 2009). In light of this and the easy entry of 
nanoparticles both beneficial and otherwise, this study investigates the interaction and 
toxicological influence of a component of lung surfactant on AgNP toxicity on the lung. 
Pulmonary surfactant is composed of a variety of complex phospholipids, lipids and surfactant 
specific proteins. Dipalmitoylphosphatidylcholine (DPPC) is the most abundant phospholipid, 
comprising 70-80% of total surfactant. The overall function is to reduce surface tension at the 
liquid-air interface at the bronchoalveolar surface (Kumar & Bohidar, 2010; Serrano & Perez-
Gil, 2006). During inspiration, the surfactant lowers surface tension near equilibrium, 
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minimizing the work of breathing. During exhalation, surface tension values are reduced thus 
stabilizing the lungs at low air volume and preventing pulmonary oedema (Bakshi et al, 2008). 
In order to perform these functions all of the components of lung surfactant are required to 
work in conjunction. In recent studies DPPC has been used to improve the properties of 
liposomes to produce more successful in vivo methods of delivery. For example its inclusion 
in liposome encapsulation of cancer drugs can improve delivery of the complete drug 
concentration to tumour cells improving killing of cancer cells (Yavlovich et al, 2011). 
The aim of this investigation is to assess the toxic response of a carcinogenic lung cell line, 
A549, to in vitro exposure to AgNP.  The ability of DPPC to affect or modify any observed 
toxicity was also established. The physiochemical characteristics of nanoparticles play a vital 
role in toxicological investigation and as such analysis of AgNP was performed using dynamic 
light scattering analysis, UV-vis spectroscopy and zeta potential analysis.  The effect of DPPC 
components on the size distribution and agglomerative state of AgNP was also investigated. A 
cytotoxic profile was carried out using a number of viability assays including 3-(4, 5-
Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), alamar blue and a 2’, 7’-
dichlorofluorescin diacetate (DCFH-DA) plate assay to detect intracellular oxidative stress 
induced by exposure. The influence of DPPC on the outcome of toxicity was also assessed 
using the same assays and any interaction of DPPC with the physiochemical characteristics of 
AgNP determined. A subsequent study was performed to monitor the effect on the release of 
inflammatory markers interleukin-8 (IL-8) and tumour necrosis factor alpha (TNF-α) upon 
exposure to AgNP in the presence of DPPC. 
 
 
Materials and Methods 
 
Test materials and reagents 
Polyvinylpyrrolidone (PVP) coated silver (Ag) nanopowder of < 100nm Catalogue No: 
758329, was purchased from Sigma-Aldrich Ltd (Dublin-Ireland). PVP coating was confirmed 
by XRD analysis. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
Catalogue No: M5655 and 2’,7’- dichlorofluorescin diacetate (DCFH-DA) Catalogue No: 
D6883 as well as cell culture media, supplements and trypsin were all purchased form Sigma-
Aldrich Ltd (Ireland). Alamar blue (AB) was purchased from Biosciences (Dublin, Ireland).  
Dipalmitoylphosphatidylcholine (DPPC) was purchased from Sigma-Aldrich (Ireland). 
 
Cell Culture 
A549 (ATCC: CCL-185) an immortalized carcinogenic alveolar cell line was employed in this 
study. A549 cells were cultured in RPMI-1640 medium supplemented with 10% foetal bovine 
serum (FBS), 2mM L-glutamine and 45 IU/ml penicillin and 45 IU/ml streptomycin at 37°C 
in humidified 5% CO2. All cell culture media including FBS other reagents and supplements 
were purchased from Sigma-Aldrich Ltd (Ireland). 
Characterization of nanoparticles 
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Prior to the cytotoxicity testing, pristine AgNP were characterized as purchased and as prepared 
in various suspensions in the presence and absence of DPPC. The solutions of AgNP (15µg/ml) 
were prepared in deionised water (dH2O) and RPMI-1640 cell culture media using a bath-
sonicator for 20 minutes (Degussa-Ney ULTRAsonik 57X 50/60 Hz, California, USA) prior 
to size and zeta potential analysis. Dynamic light scattering and zeta potential measurements 
were performed with the aid of a Malvern ZetaSizer Nano ZS (Malvern Instruments, 
Worcestershire, UK) operating with version 5.10 of the systems Dispersion Technology 
Software (DTS Nano). For size measurement DTS0012 disposable sizing cuvettes were used. 
The samples were equilibrated at 25°C for 2 minutes before each measurement. For zeta 
potential analysis, DTS1060T clear disposable zeta cells were used and measurements were 
performed with the automatic model setting, using a voltage of five volts to minimize artefacts 
and charring of sample proteins during analysis.  
Scanning Electron Microscopy (SEM) was also employed to estimate nanoparticle size from 
the images produced by this technique. A Hitachi SU 6600 FESEM instrument was used to 
obtain images of the AgNP. First the SEM was calibrated with Au on Carbon standard provided 
by Agar Scientific (Essex, UK). Samples were prepared by dispersing particles (1.56µg/ml) in 
ethanol by sonication 750 watts Ultrasonic Processor tip (Branson Ultrasonics, Ultra sonic 
processor VCX-750W) at 40% amplitude for a total of 45 seconds. Samples were spin coated 
onto pure silicon wafer which had been thoroughly cleaned by sonication in acetone for 30 
minutes followed by boiling in propanol for 30 minutes. Silicon wafers were then left to air dry 
in a dust free environment and the nanoparticle sample was then spin coated onto the wafers 
24 hours prior to measurement. 
The specific area of AgNP was established with a Micrometrics GEMINI BET. BET sample 
holders were filled with a known mass of powdered nanoparticles and measured. The sample 
was degassed for 2 hours at room temperature with nitrogen gas prior to analysis. Nitrogen gas 
was used as the absorptive gas and a multipoint method was used in the estimation of specific 
surface area.  
 
Cytotoxic evaluation 
The AB and MTT assays were performed for assessment of cytotoxicity of AgNP to the three 
cell lines. The test used a range of eight concentrations of AgNP (3.91-500µg/ml) in which 
effects were likely to occur, this in turn allowed inhibitory concentration (IC50) to be calculated 
(Murphy et al, 2015). In all cases results were compared to an unexposed control, eliminating 
any dependence of the cell line exposures on well type, seeding efficiency and numbers, 
exposure times and volumes. A stock suspension of AgNP (500µg/ml) was prepared aseptically 
from which different concentrations of nanoparticles were prepared in RPMI-1640 cell culture 
media followed by bath-sonication for 20 minutes (Degussa-Ney ULTRAsonik 57X, 
California, USA). As a positive control 10% DMSO was prepared in cell culture media. For 
cytotoxic analysis of nanoparticles in the presence of DPPC a concentration of 0.25µg/ml was 
chosen based on previous studies (Herzog et al, 2009). A stock solution of this test 
concentration (0.25µg/ml) was prepared for DPPC in RPMI-1640. Using this test 
concentration, a stock suspension of AgNP (500µg/ml) was prepared aseptically from which a 
range of nanoparticle concentrations (3.91-500µg/ml) was prepared. 
 
Alamar Blue assay 
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For the AB assay, cells were seeded in 96 well microtitre plates (Nunc, Denmark) at a density 
of 1 x 10⁵, 5 x 104, 4 x 104 and 3 x 104 cells/ml for 24, 48, 72 and 96hr exposures respectively 
in 100µl of respective media containing 10% FBS. At least three independent experiments were 
conducted with six replicate wells employed per concentration per plate in each independent 
experiment. After 24 hours of cell attachment, plates were washed with 100µl/well PBS and 
treated with increasing concentrations of AgNP (3.91-500µg/ml) prepared in culture media for 
24, 48, 72 and 96 hours. All incubations were performed at 37°C in a 5% CO2 humidified 
incubator. The assay was performed according to manufacturer’s instructions. Briefly, control 
media and test exposures were removed, cells were rinsed with 100µl PBS and 100µl of AB 
solution (5% [v/v] solution of AB) prepared in fresh media with no added supplements were 
added to each well. After 3 hour incubation AB fluorescence was measured at excitation and 
emission wavelength of 531nm and 595nm respectively in a SpectraMax® M3 Microplate 
reader (Molecular Devices, California, USA). Wells containing AB solution and media only 
were used as blanks. For this assay the mean fluorescence units for six replicate cultures were 
calculated for each exposure treatment. Acellular studies were performed with test particles 
and the AB dye to confirm no interference of the particle with dye conversion (Gupta 
Mukherjee et al, 2012). 
 
 
MTT assay 
As with the AB assay a parallel set of three plates were set up for the MTT assay, seeded and 
exposed as previously described. After the same exposure times as AB assay, 24, 48, 72 and 
96hr exposure or test medium was removed. Cells were washed with 100µl PBS and 100µl of 
freshly prepared MTT solution (5mg/ml MTT in media {without supplements}) was added to 
each well. After 3 hour incubation the solution was removed, cells were rinsed 100µl PBS and 
100µl MTT fixative (DMSO) was added to each well. Plates were shaken at 240rpm for 10 
minutes. Following this step the supernatant was removed and transferred to a new 96 well 
plate for analysis as it has been observed that sedimentation of AgNP on the bottom of wells 
interferes with absorbance readings producing higher values. Absorbance was read at 595nm 
in a SpectraMax® M3 Microplate reader (Molecular Devices, California, USA). 
 
Clonogenic assay 
The assay was performed in six well plates (Nunc, Denmark) each seeded with 1ml of cell 
suspension in media, 400 cells/ml and 1ml of media alone. Cells were allowed to attach for 12 
hours to ensure there are single cells at the bottom of each well at the time of exposure. After 
the attachment period, wells were washed with PBS 2ml/well and then cell were treated with 
increasing concentrations of AgNP (3.91-500µg/ml) prepared in RPMI or AgNP prepared in 
RPMI with DPPC, 2ml/well. Plates were then incubated for 10 days, 37°C 5% CO2 in a 
humidified incubator (Herzog et al, 2007; Casey et al, 2008). Two replicate wells on each plate 
were used for controls. This was performed for each test concentration. Following incubation, 
test exposures and control were removed and wells washed with 2ml/well PBS. Finally cells 
were fixed and stained with 20% carbol fuschin in dH2O (BDH, Poole, UK) and colonies were 
manually counted. For all assays 10% DMSO prepared in supplemented media was used for 
positive control. 
 6 
 
 
Reactive Oxygen Species (ROS) studies 
Intracellular oxidative stress was quantified using a 2’, 7’-dichlorofluorescin diacetate (DCFH-
DA) plate assay to detect intracellular hydroperoxides and probe for a wide range of ROS. 
Confluent cells were trypsinized and seeded at a density of 1 x10⁵ cells/ml prepared in media, 
onto 96 well black bottomed plates (Nunc, Denmark) and allowed to attach for 24 hours. Six 
independent experiments were performed with six replicate wells for control, positive control 
and test concentrations on each plate. A working stock of 20µM DCFH-DA in PBS was 
prepared and all test concentrations, positive and unexposed negative controls were prepared 
in this working stock and exposed to cells. The negative control consisted of 20µM DCFH-DA 
in PBS only and the positive control was 5µM hydrogen peroxide (H2O2) prepared in working 
stock. AgNP test concentrations (3.91-500µg/ml) and AgNP test concentrations with DPPC 
(0.25µg/ml) were prepared in the DCFH-DA/PBS working stock. Prior to cellular testing, 
acellular studies were performed with the test particles and the DCF dye at all test scenarios to 
confirm no reduction of the dye due to AgNP interference. No reduction of DCFH-DA by 
AgNP was noted. 
After 24 hours of attachment, the media was removed and wells were washed with PBS, 
100µl/well. Cells were then treated with 100µl of positive control, negative control and test 
concentrations and plates are incubated for 15min, 30 min, 1hr, 2hr, 3hr, 4hr, 5hr and 6hr. The 
rate of intracellular ROS production is monitored at each time point by the emission of DCFH-
DA at 529nm by excitation at 504nm at the various time points (plates were re-incubated after 
each time point reading). Readings were performed on a SpectraMax® M3 Microplate reader 
(Molecular Devices, California, USA). 
 
Inflammatory Studies 
Release of inflammatory markers interleukin-8 (IL-8) and tumour necrosis factor alpha (TNF-
α) were studied using Human ELISA Max™ deluxe sets for IL-8 and TNF-α of Biolegend Inc 
(San Diego, California). Supernatant samples were collected prior to inflammatory studies. 
Sample collection was performed in six well plates (Nunc, Denmark) each seeded with 1ml of 
cell suspension in RPMI, 5 x 104 cells/ml. Plates were incubated at 37°C for 24 hours. After 
incubation cells were treated with 1ml of increasing concentrations of AgNP (3.91-500µg/ml). 
Plates were incubated and cell supernatant collected at designated time intervals, 1 through 6 
hours. After sample collection inflammatory studies were performed using ELISA assay as per 
manufactures instructions. All reagents and standards were prepared as per instructions. 
Absorbance was read at 450nm and 570nm within 30 minutes using a SpectraMax® M3 
Microplate reader (Molecular Devices, California, USA). 
 
Statistical analysis 
At least three independent experiments were performed for each cytotoxicity endpoint. 
Results for each assay were expressed as a percentage of unexposed control ± standard 
deviation with control values set as 100%. Statistically significant differences between 
samples and their respective controls were calculated using the statistical analysis package 
InStat. Statistically significant differences were set at p<0.05. Normality of data was 
confirmed with Q-Q percentile plots and Kolmogorov-Smirnov tests. Equality of variances 
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was evaluated using Levène tests. One-way analysis of variances (ANOVA) followed by 
Dunnett’s multiple comparison tests were carried out for normally distributed samples with 
homogeneous variances. Non-parametric tests, namely Kruskal-Wallis followed by Mann-
Whitney-u-tests were applied to samples without normal distribution and/or inhomogeneous 
variances. Cytotoxicity data (where appropriate) was fitted to a sigmoidal curve and a four 
parameter logistic model used to calculate the Inhibitory Concentration (IC50) values. The 
IC50 value refers to a concentration of a compound where a 50% effect is observed in this 
case a reduction in cell viability. IC50 values were reported as ±95% confidence intervals. 
IC50 values were estimated using XLfit3™, a curve fitting add on for Microsoft® Excel (ID 
Business Solutions, UK).  
 
Results 
Particle characterization  
The particles utilized in this study (PVP coated, Sigma-Aldrich, Ireland) were characterized 
using SEM analysis (figure 1) which demonstrated spherical particles with an average size of 
50-70nm. The size is representative of pristine particles as purchased suspended in dH2O. For 
more detailed sizing analysis DLS was used to provide a rough overview of particle interaction 
with different biological media providing a more realistic view of how AgNP will be presented 
to cells and give insight into the response they may produce. 
Figure 2 demonstrates DLS measurements on AgNP suspended in dH2O, in RPMI cell culture 
media and in the presence of DPPC. A representative concentration of AgNP (15.6µg/ml) that 
produces a biological effect was chosen. Two peaks are demonstrated in analysis of AgNP 
alone with the greatest number of particles falling in the range of 34nm ±3.5. The broader peak 
can be attributed to particle agglomeration. A slight shift in hydrodynamic diameter was 
observed in preparations of AgNP in RPMI. Dispersed in RPMI alone two clear peaks were 
observed one representing RPMI itself and the other at approximately 40nm representing 
AgNP. The addition of DPPC causes little change in hydrodynamic diameter but produces a 
larger peak at the 20-40nm range suggesting possible isolation of particles from larger 
agglomerates with its addition to the system.  
While DPPC appears to have no influence on particle size the data indicate an influence on 
particle agglomeration. As such UV-vis absorption was performed to determine any interaction 
between the various components of the different suspensions. No interaction between 
components was demonstrated indicating that a secondary toxicity due to depletion of nutrients 
would be unlikely. 
Zeta potential analysis was performed on the same particle suspensions as used for sizing 
analysis and demonstrates the overall stability of the system. A system is unstable when 
values fall within the range of 30mV to -30mV. It was noted that AgNP suspended in dH2O 
fell within this range, less than 30mV, indicating particles were unstable an unusual result as 
particles are PVP coated. When suspended in cell culture media and in the presence of DPPC 
the system was stable. The addition of DPPC was noted to have no impact on the overall 
stability. 
 
Cytotoxicity Testing 
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The cytotoxicity of AgNP on A549 cells was assessed using the viability assays MTT, Alamar 
blue (AB) and a DCF-DA plate assay to detect intracellular oxidative stress. The influence of 
DPPC on the observed toxicity was investigated using the same array of toxicological assays. 
A positive control of 10% DMSO was employed for all viability assays and 5µM H2O2 was 
employed for ROS studies. The ability of AgNP to induce an inflammatory response and the 
impact of DPPC on this response was also investigated using ELISA based assays for the 
detection of IL-8 and TNF-α release. Cytotoxicity data for AgNP exposure is presented in table 
1. The results of the MTT assay are presented for toxicity testing in the presence and absence 
of DPPC. Both MTT and AB assays were performed. Results for AB assay not shown, data is 
represented in table 1. 
Figure 3 represents the cytotoxic response of A549 cells to AgNP exposure as determined by 
the MTT assay. Reduction in cell viability due to exposure occurred in a dose and time 
dependent manner. A significant reduction in mitochondrial integrity was observed after 48 
hours at all AgNP concentrations. Significant reduction after 72 and 96 hour exposures was 
noted at concentrations of 15.6μg/ml and above compared to the unexposed control, while a 
significant reduction in cell survival at all exposure times occurred at 31.25μg/ml and above.  
A DCF-DA plate assay was employed to detect any ROS production in response to AgNP 
exposure over a 6 hour period with readings taken every hour. This study indicated no 
intracellular ROS production in response to exposure to AgNP. The generation of 
intracellular hydro peroxides was noted at the highest concentration 500μg/ml with 
production increasing in a time dependant manner. Induction of ROS was first detected at this 
concentration after 15 minutes, with the highest induction observed after 1 hour. Results are 
not shown. 
The ability of DPPC to influence toxicity was investigated using the same array of cyto-
toxicological tests. 
Figure 4 displays the toxic response of A549 cells to AgNP in the presence of 0.25μg/ml DPPC. 
A dose dependant response to AgNP exposure was observed. A change in toxicity was not 
noted, however the pattern appeared altered in the presence of DPPC. A short delay in toxicity 
between 48 and 72 hours was observed after which a significant reduction in cell viability 
occurred. Significant reduction in cell survival to all exposure concentrations was noted after 
72 hours. After 24 hours, significant loss in cell viability was observed at a concentration of 
15.6μg/ml with a significant decline at 7.8μg/ml and above following 96 hour exposure. 
Significant cell death compared to the unexposed control at all exposure intervals was observed 
at 62.5μg/ml and above. The addition of DPPC may alter the pattern of toxicity by causing a 
delay in toxicity in the first 48 hours, after which a significant reduction in viability is observed 
at 72 hours.  
The delay and increase in viability at lower nanoparticle concentrations at 48 hours may result 
from surviving cells beginning to replicate. DPPC is a surfactant and as such will associate 
with the nanoparticles surface. This association may result in a “Trojan horse” effect or delayed 
toxicity as observed at lower concentrations in the first 48 hours. After this time it is possible 
the DPPC coating has been removed following nanoparticle entry to the cell and trafficking to 
various cellular compartments allowing the naked nanoparticle to exert its toxic effects (Wang 
et al, 2013). 
In addition to cytotoxic evaluation, the clonogenic assay was performed to analyse the effect 
of longer exposures to AgNP. This assay was performed over a 10 day exposure period and 
monitored the ability of cells to form colonies in the presence of AgNP. The ability of cells to 
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proliferate following AgNP exposure with the addition of DPPC was significantly reduced 
compared to the unexposed control. This was observed at all exposure concentrations. It was 
found that the ability of A549 cells to proliferate was inhibited at the lowest concentration of 
3.91μg/ml and above with no colony formation and therefore no cell survival at concentrations 
of 62.5μg/ml and above, as shown in Figure 5. Interestingly it appeared that the addition of 
DPPC increased the toxicity of Ag nanoparticles towards cells with significant reductions in 
colony formation compared with exposure to AgNP alone. 
A DCF-DA plate assay was employed to investigate the effect of DPPC on ROS generation in 
A549 cells following AgNP exposure. From the data it appeared that in the presence of DPPC 
there was increased generation of intracellular ROS from a dose of 31.25µg/ml and above. 
Figure 6 illustrates ROS production in a dose and time dependant manner. Induction was 
detected at concentrations as low as 31.25μg/ml after 15 minutes exposure, with maximum 
production noted at 500μg/ml after 30 minutes. ROS production was detected up to 6 hours 
after initial exposure at a concentration of 500μg/ml and up to 4 hours after initial exposure at 
250μg/ml.  Significant increases were noted at doses of 62.5µg/ml after 30 minutes, 125µg/ml 
after 15 and 30 minute exposures and at higher doses significant generation was observed from 
15 to 30 minutes and 2 to 3 hours at 250µg/ml and at 15 minutes to 5 hours at 500µg/ml.  From 
the data it is clear that the presence of DPPC mediates oxidative stress in A549 cells by 
increasing intracellular ROS formation following AgNP exposure. 
 
Inflammatory Studies 
The ability of AgNP to induce IL-8 and TNF-α production and the effect of the addition of 
DPPC was investigated using ELISA based assays.  
Figure 7 demonstrates IL-8 release following exposure to AgNP. At the highest concentration, 
50µg/ml, production of IL-8 was observed after 2 hours. Levels were shown to decline after 3 
hours with a second peak in levels demonstrated after 4 hours. The lower dose of AgNP caused 
IL-8 release initially after exposure with increasing generation up to 2 hours after exposure. A 
similar reduction in levels was detected at 3 hours after which an increase in IL-8 was detected 
at 4 and 6 hours. A significant increase in IL-8 compared to the unexposed control was noted 
at 2, 3, 4 and 6 hours at a concentration of 50µ/ml and at all time intervals at 25µg/ml.  The 
data suggest that at sub-lethal levels of AgNP, 25µg/ml, a more immediate and long lived 
inflammatory response is initiated compared to higher toxic doses. 
Figure 8 represents IL-8 release in A549 cells following AgNP exposure with the addition of 
DPPC. The data show that the presence of DPPC alters the pattern of IL-8 release in cells. The 
levels of IL-8 detected were substantially higher than exposure to AgNP alone and production 
occurs at a faster rate with greater levels detected after 1 hour exposure. Similar to figure 7 a 
second spike in release was detected at 6 hours. The presence of DPPC generated an immediate 
and prolonged inflammatory response compared to exposure to AgNP alone as illustrated by 
IL-8 levels detected at 1 and 6 hours. Significant release was noted at 1, 2, 3 and 6 hours for 
all doses compared to the unexposed control. While DPPC leads to an enhanced production of 
IL-8, the pattern appears not to be dependent on concentration suggesting that regardless of 
AgNP dose the same biological response is initiated.  
Figure 9 illustrates TNF-α release following AgNP exposure. Generation of TNF-α at a dose 
of 25µg/ml was immediate and short lived with peak levels detected after 1 hour and a rapid 
reduction observed at 2 hours and above. A similar pattern was detected at the highest dose 
 10 
 
with high levels detected after 1 hour followed by a swift decline. However as demonstrated 
with IL-8, a second spike in TNF-α levels occurs at 6 hours. Significant TNF-α release was 
detected after 1 hour following 25µg/ml exposure and after 1, 2, 3 and 6 hours after 50µg/ml 
exposure. 
In the presence of DPPC (figure 10) substantially lower levels of TNF-α were released 
compared to AgNP alone. TNF-α was generated after 1 hour exposure with a decline in levels 
detected after at 2 hours. Unlike exposure to AgNP alone, the second increase in levels was 
detected at 3 hours and gradually increased with time. Significant increases in TNF-α release 
were noted at 1, 3, 4 and 6 hours at a dose of 50µg/ml and at 1, 4 and 6 hours at 25µg/ml. It 
appears the presence of DPPC produces a prolonged inflammatory response similar to that 
observed with IL-8 release. The addition of DPPC also modifies the pattern of TNF-α release, 
which similar to IL-8, is not dependent on AgNP concentration. 
 
Discussion 
It is apparent from the literature that exposure to nanoparticles is becoming more widespread 
mainly through their continued incorporation into consumer products. As a result there is an 
increasing incidence of direct contact between nanoparticles and biological systems. This 
growing concern of nanoparticle exposure highlights the need for a complete and thorough 
toxicological investigation to determine what effects are induced and what factors within 
biological systems play a role in the resulting effects. 
The physiochemical characteristics of AgNP play an important role in how they will interact 
with biological systems. Primarily the size and associated surface area, shape and chemical 
composition have all been shown to be of great importance to nanoparticle toxicity and must 
be considered when interpreting toxicological data (Sur et al, 2012; Warheit, 2007). As well as 
nanoparticle characteristics, the influence of ion release on toxicity must also be considered 
and further investigation is required to determine how much toxicity can be attributed to ions 
and the particle itself (Beer et al, 2012; Navarro et al, 2008; Kim et al, 2009). In this instance 
a thorough characterization of nanoparticles was undertaken yielding a size of 34nm ± SD 3.5 
and no interaction between components was evident. Despite this, the effect individual 
components play on resulting toxicity must be considered as physiochemical characterization 
can never truly represent interactions occurring in vitro or in vivo. 
Table 1 displays cytotoxic data for both viability assays. The AB assay demonstrates an 
increase in IC50 values at 72 and 96 hours. This assay has multiple sites of conversion within 
the cell and thus gives an indication into both viability and general cell function. As such the 
increase in cell viability observed may be attributed to cell recovery. The A549 cell line has a 
doubling time of 22 hours and it is possible that after the first 48 hours of exposure where 
toxicity is observed any surviving cells begin to replicate again slowly resulting in an increase 
in IC50 values. This was also observed at 96 hours with the addition of DPPC. In the MTT assay 
which is indicative of mitochondrial integrity only, a time dependant reduction in values was 
observed. Exposure to AgNP was also noted to induce an inflammatory response with release 
of IL-8 and TNF-α. The presence of DPPC significantly altered the levels of release induced 
by exposure on A549 cells. The difference in levels released when DPPC was present compared 
to AgNP exposure alone was found to be statistically (p<0.05) significant at all exposure 
concentrations and time points.  
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The mechanism of cell death caused by AgNP can be related to oxidative stress. Mitochondrial 
cell death by ROS generation has been described in a number of studies as the primary 
mechanism of nanoparticle related cell death with its generation forming a critical step in 
initiation of apoptotic pathways (Martindale & Holbrook, 2002; Sastre et al, 2000; Piao et al, 
2011). ROS are generated under normal physiological conditions and are continually 
eliminated by naturally occurring antioxidants. Under certain “stressful” conditions cells are 
unable to maintain homeostasis as increased quantities of ROS are produced which overwhelm 
the antioxidant systems (Arora et al, 2008; Piao et al, 2011). Previous studies have shown that 
AgNP not only induce ROS but can also inhibit antioxidants such as glutathione (Arora et al, 
2008; Hussain et al, 2005; Chairuangkitti et al, 2013; Piao et al, 2011). This process may be in 
part due to lipid peroxidation caused by nanoparticle exposure. AgNP and ZnO have been 
identified as a cause of lipid peroxidation enhancing ROS production while also quenching 
naturally occurring antioxidants (Premanathan et al, 2011; Adeyemi & Faniyan, 2014). This 
response induces downstream dysfunction such as inflammation and DNA damage within the 
cell culminating in cell death (Nel et al, 2006). While mitochondrial involvement appears to 
be the mechanism of cell death, other pathways have been hypothesised. Death via a ROS-
independent pathway has also been observed in A549 cells following exposure to AgNP. This 
results in cell cycle arrest rather than cell death by interfering with a regulatory protein critical 
in progression of the cell cycle (Chairuangkitti et al, 2013). This may partially explain the lack 
of ROS induction observed following AgNP exposure but with a reduction in viability still 
evident. Cells may be arrested at various stages of the cell cycle without the involvement of 
ROS following AgNP exposure as demonstrated in the data.  
The induction of oxidative stress is a critical step in the biological response to nanoparticle 
exposure and causes a number of cellular implications including an enhanced inflammatory 
response. Excessive ROS production leads to activation of a number of pro-inflammatory 
cytokines including IL-8 and TNF-α and within the lung which have been implicated in certain 
respiratory disorders (Henricks & Nijkamp, 2001; Zuo et al, 2013). IL-8 is involved in the 
activation and migration of cells such as neutrophils, during acute inflammation. It can also up-
regulate adhesion molecules involved in adherence and migration of cells through the 
endothelium (Feghali & Wright, 1997; Lim et al, 2012). The lung epithelium in particular is 
an important source of IL-8 and as such is a key player in the mediation of lung inflammation 
(Donaldson et al, 1998). IL-8 has been the focus of a number of studies related to nanoparticle 
toxicity, with its release implicated in the recruitment of inflammatory cells to the lung (Singh 
et al, 2007). Specifically, following AgNP exposure, significant release of IL-8 from 
macrophages has been demonstrated, with both particle size and the generation of ROS playing 
a crucial role in its release (Lim et al, 2012; Park et al, 2011). 
TNF-α is a potent cytokine involved in the initiation and maintenance of inflammation (Nathan, 
2002). TNF-α can mediate a number of responses directly such as fever and, tissue damage, as 
well as causing indirect effects by downstream signalling leading to the activation of other 
inflammatory factors including IL-6 (Feghali & Wright, 1997; Warren, 1990).  This cytokine 
has been implicated in the development of pulmonary fibrosis following silica micro-particle 
exposure causing increased endothelial permeability to macromolecules as well as its up-
regulation following exposure to various nanoparticles (Napierska et al, 2012; Henning et al, 
1997; Pryhuber et al, 2003; Piguet et al, 1990). The detection of increased levels of both IL-8 
and TNF-α following exposure implicates AgNP in the inflammatory process with an 
augmented response observed following the addition of DPPC. The increased levels of IL-8 in 
particular correlates to the ROS generation observed following its addition. In the case of IL-
8, an immediate release is observed in the presence of DPPC and its early release has been 
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proposed as a potential bio-marker for acute inflammation in relation to AgNP exposure which 
the data presented here supports (Lim et al, 2012; Park et al, 2011).  
The ability of the DPPC to increase and prolong the activation of both cytokines compared to 
AgNP alone suggests progression from acute to chronic inflammation. It has been proposed 
that high levels coupled with sustained release of these cytokines may prevent resolution 
resulting in the development of chronic inflammation. It was observed that in certain cases it 
was not the highest AgNP concentration that generated the greatest release of cytokines. This 
is not surprising as high concentrations can cause cells to enter a death process whereas lower 
concentrations can induce an inflammatory. Lim et al demonstrated cytokine gene expression 
at sub lethal concentrations of AgNP, in particular IL-8 release at 2.5µg/ml (Lim et al, 2012). 
DPPC is a major component of lung surfactant produced by type II alveolar cells, similar to 
A549 cells, and as such has been used as a surfactant model in numerous toxicity studies 
(Kumar & Bohidar, 2010; Dobbs et al, 1987; Foucaud et al, 2007; Porter et al, 2008; Sager et 
al, 2007). Employed as a particle coating, DPPC has been shown to exert a protective effect 
preventing degradation and allowing controlled release of encapsulated drug compounds; 
however there is increasing evidence of its contribution to toxicity and induction of oxidative 
stress (Kaviratna & Banerjee, 2009; Herzog et al, 2009; Foucaud et al, 2007; Hamilton Jr et al, 
2008). The data highlight the importance of ROS in cell toxicity particularly in the presence of 
DPPC. DPPC appears to increase oxidative stress within the cell in agreement with other 
studies where it was also found that its addition significantly increased ROS production in 
A549 cells (Herzog et al, 2009; Foucaud et al, 2007). An investigation into different variations 
of silica nanoparticles including iron- and titania- containing particles, noted increased levels 
of intracellular ROS generation. This was believed to occur through nanoparticle entry by a 
Trojan-horse type mechanism dependant on surface chemistry of the particles (Limbach et al, 
2007). A similar theory can be applied to this study and the increased oxidative stress observed 
following the addition of DPPC. It is possible that interaction with DPPC causes particles to 
have a higher level of dispersion, increasing the surface area available for interaction and 
therefore increasing the likelihood of cellular uptake - resulting in generation of ROS.  It must 
also be considered that the surface chemistry and activity of particles is altered by DPPC, 
changing its toxicity, making the particles more reactive and thus more toxic (Herzog et al, 
2009; Hamilton Jr et al, 2008; Buford et al, 2007). 
The observation that cell death can occur via a number of pathways in A549 cells indicates a 
two tiered mechanism of cell death, cell cycle arrest and ROS mediated mitochondrial 
dependant cell death (Piao et al, 2011). The data in this study suggest that while not changing 
nanoparticle toxicity DPPC may influence death pathways as demonstrated by the induction of 
oxidative stress. The observation that DPPC leads to ROS generation in A549 cells suggests a 
possible switching from a ROS independent pathway as described by Chairuangkitti et al, 2013 
causing cell cycle arrest to a ROS dependent pathway culminating in apoptotic cell death 
(Chairuangkitti et al, 2013). Further mechanistic studies are required to conclusively determine 
if pathway switching due to DPPC interaction is occurring.  
 
Conclusion 
This study has demonstrated the role of DPPC in modifying toxicity, namely inducing 
intracellular ROS production. Its interaction with AgNP highlights the importance of particle-
surfactant interactions and the altered effects produced when in contact with mammalian cells. 
The data presented are in agreement with previous studies illustrating the impact on toxicity 
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caused by nanoparticle contact with DPPC and the resulting alteration in ROS generation and 
inflammatory response. These findings may contribute to developing a realistic risk assessment 
of nanoparticle exposure and the potential biological outcomes following entry and interaction 
with various fluids and surfactants present in the body. 
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Table 1 Calculated IC50 values (µg/ml) resulting from exposure to AgNps for the AB and MTT 
assays in the A549 cell line. ** Denotes where a 50% effect was not observed. IC50 values were 
calculated from the average response of three independent experiments fitted to a sigmoidal 
curve and a four parameter logistic model used to calculate Inhibitory Concentration (IC50) 
with a (p<0.05) 
Cell Line AB Assay IC50 (µg/ml) MTT Assay IC50 (µg/ml) 
 24hr 48hr 72hr 96hr 24hr 48hr 72hr 96hr 
A549 116.23 11.68 39.86 118.4 340 115 116 91 
A549 + DPPC 46.06 45.3 41.78 96.84 ** ** 49 80 
 (b) 
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Figure 1 SEM micrograph at scale bar of 500nm image pristine AgNP (a) at magnification of 
x80,000 and (b) at a magnification of x70,000 dispersed in ethanol to a concentration of 
1.56µg/ml by sonication using Ultrasonic Processor tip. 
 
 
 
 
Figure 2 Dynamic Light Scattering size (nm) particle number distribution plot of AgNP 
(15.6µg/ml) dispersed in media, dH2O and in the presence of DPPC. Data presented is the 
average of three individual experiments 
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Figure 3 Cytotoxicity of AgNP in A549 cells after 24, 48, 72 and 96hr exposure as determined 
by the MTT assay. Data expressed as percentage of control mean ± SD of three individual 
experiments. * denotes a statistically significant (p< 0.05) difference from the unexposed 
control 
 
 
Figure 4 Cytotoxicity of AgNP in A549 cells with added DPPC after 24, 48, 72 and 96 hour 
exposures as determined by the MTT assay. Data expressed as percentage of control mean ± 
SD of three independent experiments. * denotes a statistically significant (p < 0.05) difference 
from the unexposed control 
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Figure 5 Cytotoxicity of AgNP alone and with added DPPC after 10 day exposure as 
determined by the clonogenic assay. Data are expressed as percentage of control mean ± SD of 
four independent experiments. * denotes a statistically significant (p<0.05) difference from the 
unexposed control 
 
 
Figure 6 ROS generation in A549 cells after different time points of AgNP exposure in the 
presence of DPPC. Data expressed as percentage of control mean ± SD of eight independent 
experiments. * denotes a statistically significant (p<0.05) difference from the unexposed 
control 
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Figure 7 Induction of IL-8 in A549 cells at 1-4 and 6 hours following exposure to AgNP. Data 
expressed as percentage of control mean ±SD of three individual experiments. * denotes a 
statistically significant (p<0.05) difference from the unexposed control 
 
 
Figure 8 Induction of IL-8 in A549 cells at 1-4 and 6 hours following exposure to AgNP in the 
presence of DPPC. Data expressed as percentage of control mean ±SD of three individual 
experiments. * denotes a statistically significant (p<0.05) difference from the unexposed 
control 
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Figure 9 Induction of TNF-α in A549 cells at 1-4 and 6 hours following exposure to AgNP. 
Data expressed as percentage of control mean ±SD of three individual experiments. * denotes 
a statistically significant (p<0.05) difference from the unexposed control 
 
 
Figure 10 Induction of TNF-α in A549 cells at 1-4 and 6 hours following exposure to AgNP 
in the presence of DPPC. Data expressed as percentage of control mean ±SD of three individual 
experiments. * denotes a statistically significant (p<0.05) difference from the unexposed 
control 
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